Karin Kleinhans, PhD joined LSP in 2015 as an associate and became an Investment Manager in 2019. Karin is part of the LSP investment team focused on unlisted equities, and is involved in all stages of the investment process. She has been involved in a large number of LSP’s investments and is a Board Director of Cardior and Board Observer of Endotronix and Lumeon.
Prior to joining LSP, Karin was an associate in an international patent law firm where she was involved in all aspects of the patent life cycle for international clients from the biotech industry. Previously, she gained experience in clinical trials and regulatory affairs within pharmaceutical drug development. Before, Karin was a researcher at the Max-Planck Department for Stem Cell Aging and the Institute of Molecular Medicine at the University Ulm. Her research focused on the basic mechanisms of cellular and organismal aging, specifically on stem cell aging. In particular, she focused her research on the impact of DNA damage and repair on stem cell aging and regeneration. Karin participated as a speaker in scientific meetings and lead scientific collaborations with world leading experts in the stem cell and aging field. She authored a number of scientific publications and book chapters in renowned journals. Karin received her PhD from the International Graduate School in Molecular Medicine in Ulm funded by the Excellence Initiative of the German Federal and States Governments. She was awarded her Bachelor`s and Master`s Degree in Molecular Medicine where she combined medical studies with scientific research training. Karin is a former all-star field hockey team player and lives in Munich.
To contact Karin directly, email firstname.lastname@example.org or call +49 89 120 850 90.